NMPA certification (formerly CFDA) for medical devices in China is a comprehensive process designed to ensure that devices meet safety and efficacy standards. Here's a detailed explanation of the scope and applicable conditions:

Scope of NMPA Certification

1. Device Classification:

   • Class I: Low-risk devices with minimal potential for harm. Requires a simple registration process.
   • Class II: Moderate-risk devices that require more detailed review and testing.
   • Class III: High-risk devices that undergo rigorous review, including clinical trials, extensive documentation, and stringent regulatory scrutiny.

2. Types of Devices:

   • In Vitro Diagnostic Devices (IVDs): Devices used for testing specimens taken from the human body.
   • Implants: Devices that are intended to be inserted into the human body.
   • Wearable Devices: Devices intended to be worn on the body for monitoring or treatment purposes.
   • Therapeutic Devices: Devices intended to treat or manage medical conditions.

Applicable Conditions

1. Regulatory Requirements:

   • Quality Management System: Compliance with ISO 13485 or equivalent is generally required.
   • National Standards (GB): Devices must meet relevant Chinese national standards.
   • International Standards: Adherence to IEC standards may be necessary, especially for electrical safety and electromagnetic compatibility.

2. Documentation:

   • Technical Documentation: Detailed information about the device's design, intended use, manufacturing process, and performance.
   • Clinical Data: For Class II and III devices, clinical trials or studies demonstrating safety and efficacy are required.
   • Labeling: Labels and user manuals must be in Chinese and comply with NMPA requirements.

3. Testing and Evaluation:

   • Safety and Performance Testing: Devices must undergo testing to verify their safety and effectiveness.
   • Risk Management: A comprehensive risk management plan must be in place, addressing potential risks associated with the device.

4. Post-Market Requirements:

   • Surveillance: Ongoing monitoring of the device's performance and safety after it is on the market.
   • Adverse Event Reporting: Manufacturers must report any adverse events associated with their devices to the NMPA.

5. Local Representation:

   • Chinese Agent: Foreign manufacturers must appoint a local agent or distributor who acts as the point of contact with the NMPA.

Meeting these conditions is crucial for obtaining and maintaining NMPA certification. The process ensures that medical devices are safe, effective, and compliant with Chinese regulatory standards.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn